USANA preliminary Q3 net loss $6.5M, sales $214M, tax rate spikes to 471%; full-year EPS guidance cut

USANA HEALTH SCIENCES INC

2025-Q3 EPS reported $0.67 revenue$699,057,000

Q3 net sales $214M (up from $200M YoY) but operating earnings fall to $1.2M from $15.6M.
Diluted EPS loss $0.36 ($0.56 profit in Q3 2024); adjusted EPS loss $0.15.
Effective tax rate 471% due to annual rate change from 45% to 65%, adding ~$7.5M in extra tax.
Full-year sales expected at or near lower end of prior range; EPS below previously issued range.
Hiya (DTC) sales softer but still expected to achieve double-digit growth for 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.